Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 132


Detection and severity grading of COPD exacerbations using the exacerbations of chronic pulmonary disease tool (EXACT).

Mackay AJ, Donaldson GC, Patel AR, Singh R, Kowlessar B, Wedzicha JA.

Eur Respir J. 2014 Mar;43(3):735-44. doi: 10.1183/09031936.00110913. Epub 2013 Aug 29.


Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to evaluate severity of COPD exacerbations.

Mackay AJ, Donaldson GC, Patel AR, Jones PW, Hurst JR, Wedzicha JA.

Am J Respir Crit Care Med. 2012 Jun 1;185(11):1218-24. doi: 10.1164/rccm.201110-1843OC. Epub 2012 Jan 26.


Relationship between frequency, length, and treatment outcome of exacerbations to baseline lung function and lung density in alpha-1 antitrypsin-deficient COPD.

Vijayasaratha K, Stockley RA.

Int J Chron Obstruct Pulmon Dis. 2012;7:789-96. doi: 10.2147/COPD.S31797. Epub 2012 Nov 27.


Standardizing measurement of chronic obstructive pulmonary disease exacerbations. Reliability and validity of a patient-reported diary.

Leidy NK, Wilcox TK, Jones PW, Roberts L, Powers JH, Sethi S; EXACT-PRO Study Group.

Am J Respir Crit Care Med. 2011 Feb 1;183(3):323-9. doi: 10.1164/rccm.201005-0762OC. Epub 2010 Sep 2.


Impact of Prolonged Exacerbation Recovery in Chronic Obstructive Pulmonary Disease.

Donaldson GC, Law M, Kowlessar B, Singh R, Brill SE, Allinson JP, Wedzicha JA.

Am J Respir Crit Care Med. 2015 Oct 15;192(8):943-50. doi: 10.1164/rccm.201412-2269OC.


Exacerbations of chronic obstructive pulmonary disease.

Wedzicha JA, Donaldson GC.

Respir Care. 2003 Dec;48(12):1204-13; discussion 1213-5. Review.


Association between lung function and exacerbation frequency in patients with COPD.

Hoogendoorn M, Feenstra TL, Hoogenveen RT, Al M, Mölken MR.

Int J Chron Obstruct Pulmon Dis. 2010 Dec 9;5:435-44. doi: 10.2147/COPD.S13826. Review.


Daily activity during stability and exacerbation of chronic obstructive pulmonary disease.

Alahmari AD, Patel AR, Kowlessar BS, Mackay AJ, Singh R, Wedzicha JA, Donaldson GC.

BMC Pulm Med. 2014 Jun 2;14:98. doi: 10.1186/1471-2466-14-98.


COPD exacerbations: definitions and classifications.

Burge S, Wedzicha JA.

Eur Respir J Suppl. 2003 Jun;41:46s-53s. Review.


Time course and pattern of COPD exacerbation onset.

Aaron SD, Donaldson GC, Whitmore GA, Hurst JR, Ramsay T, Wedzicha JA.

Thorax. 2012 Mar;67(3):238-43. doi: 10.1136/thoraxjnl-2011-200768. Epub 2011 Oct 18.


Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease.

Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA.

Am J Respir Crit Care Med. 2000 May;161(5):1608-13.


Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.

Thomsen M, Ingebrigtsen TS, Marott JL, Dahl M, Lange P, Vestbo J, Nordestgaard BG.

JAMA. 2013 Jun 12;309(22):2353-61. doi: 10.1001/jama.2013.5732.


Relationship between the GOLD combined COPD assessment staging system and bacterial isolation.

Aydemir Y, Aydemir Ö, Kalem F.

Int J Chron Obstruct Pulmon Dis. 2014 Sep 27;9:1045-51. doi: 10.2147/COPD.S70620. eCollection 2014.


A comparison of three multidimensional indices of COPD severity as predictors of future exacerbations.

Motegi T, Jones RC, Ishii T, Hattori K, Kusunoki Y, Furutate R, Yamada K, Gemma A, Kida K.

Int J Chron Obstruct Pulmon Dis. 2013;8:259-71. doi: 10.2147/COPD.S42769. Epub 2013 May 31.


Exacerbation-related impairment of quality of life and work productivity in severe and very severe chronic obstructive pulmonary disease.

Solem CT, Sun SX, Sudharshan L, Macahilig C, Katyal M, Gao X.

Int J Chron Obstruct Pulmon Dis. 2013;8:641-52. doi: 10.2147/COPD.S51245. Epub 2013 Dec 10.


Defining COPD exacerbations: impact on estimation of incidence and burden in primary care.

O'Reilly JF, Williams AE, Holt K, Rice L.

Prim Care Respir J. 2006 Dec;15(6):346-53. Epub 2006 Oct 24.


A longitudinal study evaluating the effect of exacerbations on physical activity in patients with chronic obstructive pulmonary disease.

Ehsan M, Khan R, Wakefield D, Qureshi A, Murray L, Zuwallack R, Leidy NK.

Ann Am Thorac Soc. 2013 Dec;10(6):559-64. doi: 10.1513/AnnalsATS.201304-100OC.


Indacaterol therapy in moderate-to-severe chronic obstructive pulmonary disease: findings from a single-center primary care cohort.

Singh MP.

Int J Chron Obstruct Pulmon Dis. 2013;8:613-9. doi: 10.2147/COPD.S53707. Epub 2013 Dec 9.


Exacerbations and lung function decline in COPD: new insights in current and ex-smokers.

Makris D, Moschandreas J, Damianaki A, Ntaoukakis E, Siafakas NM, Milic Emili J, Tzanakis N.

Respir Med. 2007 Jun;101(6):1305-12. Epub 2006 Nov 16.


Exacerbation frequency and course of COPD.

Halpin DM, Decramer M, Celli B, Kesten S, Liu D, Tashkin DP.

Int J Chron Obstruct Pulmon Dis. 2012;7:653-61. doi: 10.2147/COPD.S34186. Epub 2012 Sep 21.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk